Is It Legal to Prescribe Compounded Semaglutide in Texas?
Why This Question Does Not Have a Permanent Answer
Compounding law is built around availability. When an FDA-approved drug is in shortage, pharmacies have latitude to compound versions of it. When the shortage resolves, that latitude narrows sharply, because compounding something that is essentially a copy of an available approved drug is not what the compounding exemptions exist for. GLP-1 medications have moved across that line, which is why guidance written a year ago may describe a rule that no longer applies.
Before you rely on any answer, including this page, check the current status of the specific drug and dosage form you intend to use, and document the date you checked. That record is what shows good faith if the position changes underneath you.
The Two Kinds of Compounding Pharmacy
- A traditional pharmacy compounding for an identified patient against a valid prescription, which is the route most clinics use
- An outsourcing facility that compounds larger volumes and may supply office stock, subject to a different and stricter federal regime
The distinction matters for a Texas clinic because it determines whether the pharmacy may lawfully ship you product to hold and administer, or only dispense against a patient-specific prescription. Ordering office stock from a pharmacy that is not an outsourcing facility is a common and avoidable error.
What a Texas Clinic Must Verify About Its Pharmacy
- Current Texas licensure, including nonresident pharmacy licensure if the pharmacy ships from another state.
- Which category it operates in, and whether that permits the supply model you are planning.
- The source of the active ingredient, and documentation that it comes from a registered supplier.
- Testing and quality documentation for the preparations you will be administering.
- Whether the preparation adds another active ingredient, which changes the analysis and is often marketing rather than medicine.
- Insurance, recall procedure, and what happens to your patients if the pharmacy is shut down.
Our overview of Texas pharmacy license requirements sets out the licensure side. The clinical side stays with the prescriber, and cannot be delegated to a vendor’s assurances.
The Prescriber’s Own Exposure
A prescriber writing for a compounded preparation should be able to answer one question from the record alone: why this patient needs a compounded product rather than the approved drug. Acceptable answers are clinical, such as a documented need for a dose or formulation the approved product does not provide, or a documented intolerance to an excipient. Cost and supply convenience are not clinical reasons, and a chart that shows the whole panel of patients receiving the same compounded product looks like a business decision rather than a series of medical ones.
- Record the patient-specific rationale in each chart, not in a clinic-wide policy
- Use informed consent that states the product is compounded and not FDA-approved
- Keep lot and source documentation for anything administered in the clinic
- Do not advertise a compounded preparation by the approved drug’s brand name
- Never source from a seller that labels material for research use only
Who Enforces This
Four bodies, on different theories. The Texas Medical Board looks at the prescriber’s judgment and documentation. The Texas State Board of Pharmacy looks at the pharmacy. The FDA looks at the compounding and at any product presented as equivalent to an approved drug. The Attorney General and private plaintiffs look at advertising claims and at patient harm. A clinic can be compliant with its pharmacy contract and still be exposed on the prescribing and advertising side.
Because the rules here move faster than most compliance manuals, treat this as a standing review item rather than a launch task. Our note on common healthcare compliance mistakes makes the same point about policies that were accurate when written and were never revisited.
Frequently Asked Questions
Is compounded semaglutide banned in Texas?
There is no Texas ban by name. The question is whether the federal compounding conditions are met for the drug as it stands today, and whether your pharmacy is licensed and operating in the right category. Verify both before prescribing.
Can a clinic keep compounded GLP-1 as office stock?
Only if it is supplied by a facility permitted to provide office stock. A pharmacy compounding against patient-specific prescriptions cannot lawfully supply general stock for the clinic to hold and administer.
Does a lower price justify using a compounded version?
No. Cost is not a clinical rationale. The chart needs a patient-specific medical reason for a compounded preparation rather than the approved product.
Are peptide products sold for research use a legal alternative?
No. Material labeled for research use is not for human treatment. Using it exposes the prescriber, the clinic, and its owners to board discipline and to civil and criminal risk.
Talk to a Texas Healthcare Lawyer
We review GLP-1 supply chains and prescribing protocols against the rules as they stand at the time of review, and we re-check them when the position shifts. At Dike Law Group, healthcare law is the only thing we do. We work with physicians, nurses, and healthcare business owners across Texas, including Dallas, Frisco, Houston, Austin, and San Antonio.
Call (972) 290-1031 or visit our Texas healthcare compliance attorney page to get started. Our office is at 6160 Warren Parkway, Ste. #100, Frisco, TX 75034.
Disclaimer: This article is intended for general educational purposes only and does not constitute legal advice. For guidance specific to your situation, please consult a qualified Texas healthcare attorney.
